Dr Agarwals Health Care Ltd Share Price

Hospitals / Medical ServicesNSE
₹553.40
+0.30+0.05% (1D)
As on 20 Nov 2026 at 15:57
As of 20 Nov 2026 at 15:57, Dr Agarwals Health Care Ltd is trading at ₹553.40. The 52-week range stands at ₹401.00–₹571.90, with a market cap of ₹17.56 thousand crore. At a P/E of 158.68 and a dividend yield of 0.00%, it is a mid-cap stock in the Healthcare sector.

AGARWALEYE Price Chart

Market Cap
₹17.56K Cr
PE Ratio
158.68
ROCE
6.56%

Dr Agarwals Health Care Ltd Performance

Dr Agarwals Health Care Ltd Fundamentals

Know More
Market Cap₹17.56K Cr
ROE4.62%
P/E Ratio (TTM)158.68
EPS (TTM)₹3.49
P/B Ratio7.49
Dividend Yield0.00%
Industry P/E188.26
Book Value₹73.92
Debt to Equity0.47
Face Value₹1

Dr Agarwals Health Care Ltd Shareholding Pattern

Know More
Promoter32.3%
Foreign Institutions49.6%
Mutual Funds14.2%
Domestic Institutions1.7%
Public2.2%

Dr Agarwals Health Care Ltd Financial Statements

Know More
No data for this view.

Dr Agarwals Health Care Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Apollo Hospitals Enterprise Ltd
₹9,190.05
452.05(+5.17%)
1,32,138.86,696.5 - 9,282.5
Max Healthcare Institute Ltd
₹1,079.60
38.95(+3.74%)
1,05,080.4797.0 - 1,185.4
Manipal Health Enterprises Ltd
₹702.20
5.75(+0.83%)
92,365.8597.0 - 815.0
Aster DM Quality Care Ltd
₹779.65
40.35(+5.46%)
67,959.9519.1 - 891.3
Fortis Healthcare Ltd
₹825.00
15.15(+1.87%)
62,284.1705.0 - 1,010.1

About Dr Agarwals Health Care

Dr Agarwal's Health Care Limited was incorporated dated April 19, 2010, with the Registrar of Companies, Chennai and commenced operations pursuant to Certificate for Commencement of Business dated May 29, 2010. The Company is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the company has been a pioneer and leader in the Ophthalmology market with an established market position and healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The Company had set up eye clinics by entering into Telangana and Karnataka markets during the year 2010. In 2012, it entered the Africa market with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique. In addition to operations in India, the Company commenced international operations in 2012, which presently operate 15 Facilities in Africa, where it provide a range of eye care services, including treatments for cataract, glaucoma, diabetic retinopathy, retinal detachment, and dry eye, along with refractive surgeries, and paediatric and neuro ophthalmological. Further, the Company acquired hospitals in Maharashtra in 2017. It launched the 100th eye care facility in 2021; further it strengthened the Gujarat market by acquiring the eye care business in 2022; acquired Punjab Eye Hospital in 2023; acquired an eye care business in Varanasi, Uttar Pradesh and acquired Dr Thind Eye Care Private Limited in Punjab in 2024. The Company raised funds of Rs 3027.26 Cr through IPO by issuing an aggregate of 75,304,970 equity shares of face value of Re 1, comprising a fresh issue of 7,462,686 equity shares amounting to Rs 300 Cr and the offer for sale of 67,842,284 equity shares amounting to Rs 2727.26 Cr in January 2025. During the year 2025, Company opened 31 new primary centres. On May 27, 2025, the Company expanded its operations, by opening the first eye care facility in the NCR, New Delhi.

Parent Organisation—
Founded2010
Managing Director—
NSE SymbolAGARWALEYE

Dr Agarwals Health Care Ltd Resistance and Support levels

R3565.90R2560.63R1557.37S1546.83S2543.57S3538.30553.40

Dr Agarwals Health Care Ltd Technicals

Current Price
₹553.40 ₹0.30 (+0.05%)
Bearish
0
Bullish
12
  • 20 Day5.3%
  • 50 Day8.9%
  • 100 Day11.2%
  • 200 Day14.5%

Dr Agarwals Health Care Ltd Latest News

View More
16 NOV 2026 | Monday
Dr. Agarwal’s Health Care Limited secures media services agreement with The Good Edge Advisory
05 NOV 2026 | Thursday
Dr. Agarwal’s Health Care Limited granted equity shares to employees under its stock option scheme
20 OCT 2026 | Tuesday
Dr. Agarwal’s Health Care Limited allotted equity shares to employees under its 2022 stock option scheme
20 OCT 2026 | Tuesday
Dr. Agarwal’s Health Care Limited’s merger with Dr. Agarwal’s Eye Hospital Limited takes effect November 1, 2026
20 OCT 2026 | Tuesday
Dr. Agarwal’s Eye Hospital Limited merges with Dr. Agarwal’s Health Care Limited, effective November 1, 2026
07 OCT 2026 | Wednesday
Dr. Agarwal’s Health Care reported securities dematerialization details to BSE and NSE
05 OCT 2026 | Monday
Tribunal sanctions amalgamation of Dr. Agarwal’s Eye Hospital into Dr. Agarwal’s Health Care
29 SEPT 2026 | Tuesday
Dr. Agarwal’s Health Care Limited expands with Orbit Healthcare Services Nigeria as a subsidiary
29 SEPT 2026 | Tuesday
Sanjay Anand to step down as Independent Director of Dr. Agarwal’s Health Care in 2026
28 SEPT 2026 | Monday
Dr. Agarwal’s Health Care halts trading ahead of financial results announcement

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Dr Agarwals Health Care Ltd is ₹553.40 as of 20 Nov 2026 at 15:57.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now